The KRAS gene is found to be mutated in various types of tumors, such as pancreatic carcinoma (over 80%), colon carcinoma (40–50%), lung carcinoma (30–50%), and others [11,43,44,45,46]. This evidence concerns the gene KRAS and exocrine pancreatic carcinoma.